<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR128">
 <label>128.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Finberg</surname>
    <given-names>Robert W</given-names>
   </name>
   <name>
    <surname>Lanno</surname>
    <given-names>Riin</given-names>
   </name>
   <name>
    <surname>Anderson</surname>
    <given-names>David</given-names>
   </name>
   <name>
    <surname>Fleischhackl</surname>
    <given-names>Roman</given-names>
   </name>
   <name>
    <surname>van Duijnhoven</surname>
    <given-names>Wilbert</given-names>
   </name>
   <name>
    <surname>Kauffman</surname>
    <given-names>Robert S</given-names>
   </name>
   <name>
    <surname>Kosoglou</surname>
    <given-names>Teddy</given-names>
   </name>
   <name>
    <surname>Vingerhoets</surname>
    <given-names>Johan</given-names>
   </name>
   <name>
    <surname>Leopold</surname>
    <given-names>Lorant</given-names>
   </name>
  </person-group>
  <article-title>Phase 2b Study of Pimodivir (JNJ-63623872) as Monotherapy or in Combination With Oseltamivir for Treatment of Acute Uncomplicated Seasonal Influenza A: TOPAZ Trial</article-title>
  <source>The Journal of Infectious Diseases</source>
  <year>2018</year>
  <volume>219</volume>
  <issue>7</issue>
  <fpage>1026</fpage>
  <lpage>1034</lpage>
  <pub-id pub-id-type="doi">10.1093/infdis/jiy547</pub-id>
 </element-citation>
</ref>
